{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:47:45Z","timestamp":1793598465056,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>5q-associated spinal muscular atrophy (SMA) is a motoneuron disease caused by mutations in the survival motor neuron 1 (SMN1) gene. Adaptive immunity may contribute to SMA as described in other motoneuron diseases, yet mechanisms remain elusive. Nusinersen, an antisense treatment, enhances SMN2 expression, benefiting SMA patients. Here we have longitudinally investigated SMA and nusinersen effects on local immune responses in the cerebrospinal fluid (CSF) - a surrogate of central nervous system parenchyma. Single-cell transcriptomics (SMA: N = 9 versus Control: N = 9) reveal NK cell and CD8+ T cell expansions in untreated SMA CSF, exhibiting activation and degranulation markers. Spatial transcriptomics coupled with multiplex immunohistochemistry elucidate cytotoxicity near chromatolytic motoneurons (N = 4). Post-nusinersen treatment, CSF shows unaltered protein\/transcriptional profiles. These findings underscore cytotoxicity\u2019s role in SMA pathogenesis and propose it as a therapeutic target. Our study illuminates cell-mediated cytotoxicity as shared features across motoneuron diseases, suggesting broader implications.<\/jats:p>","DOI":"10.1038\/s41467-024-48195-3","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T16:02:02Z","timestamp":1715788922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-7386","authenticated-orcid":false,"given":"I-Na","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis Fung-Yi","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-2790","authenticated-orcid":false,"given":"Michael","family":"Heming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6642-7774","authenticated-orcid":false,"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0349-3756","authenticated-orcid":false,"given":"Giovanni","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Erdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-4608","authenticated-orcid":false,"given":"Timo","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Dambietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-7817","authenticated-orcid":false,"given":"Christina B.","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-4778","authenticated-orcid":false,"given":"Jens T.","family":"Siveke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-8650","authenticated-orcid":false,"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-9633","authenticated-orcid":false,"given":"Luisa","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-3432","authenticated-orcid":false,"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-3450","authenticated-orcid":false,"given":"Tim","family":"Hagenacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4341-4719","authenticated-orcid":false,"given":"Gerd","family":"Meyer zu Horste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"48195_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T. & Finkel, R. S. Spinal muscular atrophy. Nat. Rev. Dis. Prim. 8, 52 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"48195_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth, B. Spinal muscular atrophy: in the challenge lies a solution. Trends Neurosci. 44, 306\u2013322 (2021).","journal-title":"Trends Neurosci."},{"key":"48195_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre, S. et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16, 265\u2013269 (1997).","journal-title":"Nat. Genet."},{"key":"48195_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","volume":"28","author":"M Calucho","year":"2018","unstructured":"Calucho, M. et al. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul. Disord. 28, 208\u2013215 (2018).","journal-title":"Neuromuscul. Disord."},{"key":"48195_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-023-02554-4","volume":"145","author":"L-I Schmitt","year":"2023","unstructured":"Schmitt, L.-I. et al. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy. Acta Neuropathol. 145, 611\u2013635 (2023).","journal-title":"Acta Neuropathol."},{"key":"48195_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.nbd.2009.10.005","volume":"37","author":"D Papadimitriou","year":"2010","unstructured":"Papadimitriou, D. et al. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol. Dis. 37, 493\u2013502 (2010).","journal-title":"Neurobiol. Dis."},{"key":"48195_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/NEN.0000000000000074","volume":"73","author":"O Tarabal","year":"2014","unstructured":"Tarabal, O. et al. Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. J. Neuropathol. Exp. Neurol. 73, 519\u2013535 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"48195_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbamcr.2017.02.011","volume":"1864","author":"EK Kim","year":"2017","unstructured":"Kim, E. K. & Choi, E.-J. SMN1 functions as a novel inhibitor for TRAF6-mediated NF-\u03baB signaling. Biochim. Biophys. Acta Mol. Cell Res. 1864, 760\u2013770 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"48195_CR9","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/glia.22522","volume":"61","author":"JV McGivern","year":"2013","unstructured":"McGivern, J. V. et al. Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia 61, 1418\u20131428 (2013).","journal-title":"Glia"},{"key":"48195_CR10","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1016\/j.celrep.2019.11.013","volume":"29","author":"A Vukojicic","year":"2019","unstructured":"Vukojicic, A. et al. The classical complement pathway mediates microglia-dependent remodeling of spinal motor circuits during development and in SMA. Cell Rep. 29, 3087\u20133100.e7 (2019).","journal-title":"Cell Rep."},{"key":"48195_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","volume":"12","author":"J-C Lesbordes","year":"2003","unstructured":"Lesbordes, J.-C. et al. Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 12, 1233\u20131239 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"48195_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-003-0743-9","volume":"106","author":"S Araki","year":"2003","unstructured":"Araki, S. et al. Neuropathological analysis in spinal muscular atrophy type II. Acta Neuropathol. 106, 441\u2013448 (2003).","journal-title":"Acta Neuropathol."},{"key":"48195_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1440-1789.2008.00910.x","volume":"29","author":"S Kuru","year":"2009","unstructured":"Kuru, S. et al. An autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease). Neuropathology 29, 63\u201367 (2009).","journal-title":"Neuropathology"},{"key":"48195_CR14","first-page":"801","volume":"26","author":"M-O Deguise","year":"2017","unstructured":"Deguise, M.-O. et al. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum. Mol. Genet. 26, 801\u2013819 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"48195_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/joa.12546","volume":"230","author":"AK Thomson","year":"2017","unstructured":"Thomson, A. K. et al. Survival of motor neurone protein is required for normal postnatal development of the spleen. J. Anat. 230, 337\u2013346 (2017).","journal-title":"J. Anat."},{"key":"48195_CR16","first-page":"932","volume":"26","author":"M-T Khairallah","year":"2017","unstructured":"Khairallah, M.-T. et al. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 26, 932\u2013941 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"48195_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax9198","volume":"366","author":"M Uhlen","year":"2019","unstructured":"Uhlen, M. et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science 366, eaax9198 (2019).","journal-title":"Science"},{"key":"48195_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo, S. et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis. Nat. Commun. 11, 1773 (2020).","journal-title":"Nat. Commun."},{"key":"48195_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani, S. et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 13, 6733 (2022).","journal-title":"Nat. Commun."},{"key":"48195_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-022-04844-5","volume":"606","author":"L Campisi","year":"2022","unstructured":"Campisi, L. et al. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature 606, 945\u2013952 (2022).","journal-title":"Nature"},{"key":"48195_CR21","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati, E., Citterio, G., Bresolin, N., Comi, G. P. & Corti, S. Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease? Neurobiol. Dis. 140, 104870 (2020).","journal-title":"Neurobiol. Dis."},{"key":"48195_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","volume":"16","author":"E Mercuri","year":"2020","unstructured":"Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy \u2013 insights and challenges in the treatment era. Nat. Rev. Neurol. 16, 706\u2013715 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"48195_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"48195_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpn.2022.12.003","volume":"42","author":"FEV Scheijmans","year":"2022","unstructured":"Scheijmans, F. E. V. et al. Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment. Eur. J. Paediatr. Neurol. 42, 34\u201341 (2022).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"48195_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43856-023-00256-2","volume":"3","author":"T Nuzzo","year":"2023","unstructured":"Nuzzo, T. et al. Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients. Commun. Med. 3, 28 (2023).","journal-title":"Commun. Med."},{"key":"48195_CR26","doi-asserted-by":"publisher","first-page":"982760","DOI":"10.3389\/fncel.2022.982760","volume":"16","author":"S Bonanno","year":"2022","unstructured":"Bonanno, S. et al. Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment. Front. Cell. Neurosci. 16, 982760 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"48195_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01961-8","volume":"16","author":"M Freigang","year":"2021","unstructured":"Freigang, M. et al. Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy. Orphanet J. Rare Dis. 16, 330 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"48195_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01097-9","volume":"14","author":"M Heming","year":"2022","unstructured":"Heming, M., B\u00f6rsch, A.-L., Wiendl, H. & Meyer Zu H\u00f6rste, G. High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses. Genome Med. 14, 94 (2022).","journal-title":"Genome Med."},{"key":"48195_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.it.2020.02.005","volume":"41","author":"G Meyer Zu H\u00f6rste","year":"2020","unstructured":"Meyer Zu H\u00f6rste, G., Gross, C. C., Klotz, L., Schwab, N. & Wiendl, H. Next-generation neuroimmunology: new technologies to understand central nervous system autoimmunity. Trends Immunol. 41, 341\u2013354 (2020).","journal-title":"Trends Immunol."},{"key":"48195_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"48195_CR31","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1073\/pnas.1815961116","volume":"116","author":"E Coque","year":"2019","unstructured":"Coque, E. et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc. Natl Acad. Sci. USA 116, 2312\u20132317 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"48195_CR32","unstructured":"Biogen Inc. Spinraza prescribing information Document at https:\/\/www.spinraza.com\/content\/dam\/commercial\/spinraza\/caregiver\/en_us\/pdf\/spinraza-prescribing-information.pdf (2017)."},{"key":"48195_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14118-w","volume":"11","author":"D Schafflick","year":"2020","unstructured":"Schafflick, D. et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat. Commun. 11, 247 (2020).","journal-title":"Nat. Commun."},{"key":"48195_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","volume":"54","author":"M Heming","year":"2021","unstructured":"Heming, M. et al. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity 54, 164\u2013175.e6 (2021).","journal-title":"Immunity"},{"key":"48195_CR35","doi-asserted-by":"publisher","first-page":"22932","DOI":"10.1073\/pnas.2008523117","volume":"117","author":"A Ramesh","year":"2020","unstructured":"Ramesh, A. et al. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc. Natl Acad. Sci. USA 117, 22932\u201322943 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"48195_CR36","doi-asserted-by":"publisher","first-page":"eabb8786","DOI":"10.1126\/sciimmunol.abb8786","volume":"5","author":"JL Pappalardo","year":"2020","unstructured":"Pappalardo, J. L. et al. Transcriptomic and clonal characterization of T cells in the human central nervous system. Sci. Immunol. 5, eabb8786 (2020).","journal-title":"Sci. Immunol."},{"key":"48195_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1084\/jem.165.3.601","volume":"165","author":"J Jongstra","year":"1987","unstructured":"Jongstra, J. et al. The isolation and sequence of a novel gene from a human functional T cell line. J. Exp. Med. 165, 601\u2013614 (1987).","journal-title":"J. Exp. Med."},{"key":"48195_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","volume":"73","author":"AM Krensky","year":"2009","unstructured":"Krensky, A. M. & Clayberger, C. Biology and clinical relevance of granulysin. Tissue Antigens 73, 193\u2013198 (2009).","journal-title":"Tissue Antigens"},{"key":"48195_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"48195_CR40","doi-asserted-by":"publisher","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim, S. A. et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front. Immunol. 13, 919973 (2022).","journal-title":"Front. Immunol."},{"key":"48195_CR41","doi-asserted-by":"publisher","unstructured":"Vallejo, A. F. et al. snPATHO-Seq: Unlocking the FFPE Archives for Single Nucleus RNA Profiling. https:\/\/doi.org\/10.1101\/2022.08.23.505054. (2022).","DOI":"10.1101\/2022.08.23.505054"},{"key":"48195_CR42","doi-asserted-by":"publisher","unstructured":"Zhu, B. et al. Single-Cell Transcriptomic and Proteomic Analysis of Parkinson\u2019s Disease Brains. https:\/\/doi.org\/10.1101\/2022.02.14.480397. (2022).","DOI":"10.1101\/2022.02.14.480397"},{"key":"48195_CR43","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/cells10051030","volume":"10","author":"J Lake","year":"2021","unstructured":"Lake, J., Storm, C. S., Makarious, M. B. & Bandres-Ciga, S. Genetic and transcriptomic biomarkers in neurodegenerative diseases: current situation and the road ahead. Cells 10, 1030 (2021).","journal-title":"Cells"},{"key":"48195_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24552","volume":"79","author":"P Weydt","year":"2016","unstructured":"Weydt, P. et al. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Ann. Neurol. 79, 152\u2013158 (2016).","journal-title":"Ann. Neurol."},{"key":"48195_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492\u2013501 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"48195_CR46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh, F. L., Hansen, D. V. & Sheng, M. TREM2, microglia, and neurodegenerative diseases. Trends Mol. Med. 23, 512\u2013533 (2017).","journal-title":"Trends Mol. Med."},{"key":"48195_CR47","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/glia.24177","volume":"70","author":"G Khayrullina","year":"2022","unstructured":"Khayrullina, G. et al. Survival motor neuron protein deficiency alters microglia reactivity. Glia 70, 1337\u20131358 (2022).","journal-title":"Glia"},{"key":"48195_CR48","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/87945","volume":"7","author":"T Wyss-Coray","year":"2001","unstructured":"Wyss-Coray, T. et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612\u2013618 (2001).","journal-title":"Nat. Med."},{"key":"48195_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00441-011-1230-6","volume":"347","author":"F Caraci","year":"2012","unstructured":"Caraci, F. et al. Dysfunction of TGF-\u03b21 signaling in Alzheimer\u2019s disease: perspectives for neuroprotection. Cell Tissue Res. 347, 291\u2013301 (2012).","journal-title":"Cell Tissue Res."},{"key":"48195_CR50","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.4049\/jimmunol.1001095","volume":"185","author":"S McArthur","year":"2010","unstructured":"McArthur, S. et al. Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J. Immunol. 185, 6317\u20136328 (2010).","journal-title":"J. Immunol."},{"key":"48195_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nmeth.2900","volume":"11","author":"M Krzywinski","year":"2014","unstructured":"Krzywinski, M. & Altman, N. Comparing samples\u2014part II. Nat. Methods 11, 355\u2013356 (2014).","journal-title":"Nat. Methods"},{"key":"48195_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","volume":"28","author":"U Felderhoff-Mueser","year":"2005","unstructured":"Felderhoff-Mueser, U., Schmidt, O. I., Oberholzer, A., B\u00fchrer, C. & Stahel, P. F. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci. 28, 487\u2013493 (2005).","journal-title":"Trends Neurosci."},{"key":"48195_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jnr.1158","volume":"65","author":"T Menge","year":"2001","unstructured":"Menge, T., Jander, S. & Stoll, G. Induction of the proinflammatory cytokine interleukin-18 by axonal injury. J. Neurosci. Res. 65, 332\u2013339 (2001).","journal-title":"J. Neurosci. Res."},{"key":"48195_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-1-13","volume":"1","author":"OI Schmidt","year":"2004","unstructured":"Schmidt, O. I. et al. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. J. Neuroinflammation 1, 13 (2004).","journal-title":"J. Neuroinflammation"},{"key":"48195_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-94","volume":"11","author":"P Italiani","year":"2014","unstructured":"Italiani, P. et al. Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. J. Neuroinflammation 11, 94 (2014).","journal-title":"J. Neuroinflammation"},{"key":"48195_CR56","doi-asserted-by":"publisher","first-page":"e2023174118","DOI":"10.1073\/pnas.2023174118","volume":"118","author":"M Hartlehnert","year":"2021","unstructured":"Hartlehnert, M. et al. Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation. Proc. Natl Acad. Sci. USA 118, e2023174118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"48195_CR57","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"48195_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa151","volume":"9","author":"MD Young","year":"2020","unstructured":"Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. GigaScience 9, giaa151 (2020).","journal-title":"GigaScience"},{"key":"48195_CR59","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research 10, 979 (2021).","journal-title":"F1000Research"},{"key":"48195_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02584-9","volume":"23","author":"S Choudhary","year":"2022","unstructured":"Choudhary, S. & Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 23, 27 (2022).","journal-title":"Genome Biol."},{"key":"48195_CR61","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"48195_CR62","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"48195_CR63","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","volume":"38","author":"B Phipson","year":"2022","unstructured":"Phipson, B. et al. propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720\u20134726 (2022).","journal-title":"Bioinformatics"},{"key":"48195_CR64","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"48195_CR65","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1093\/nar\/gkv412","volume":"43","author":"R Liu","year":"2015","unstructured":"Liu, R. et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 43, e97 (2015).","journal-title":"Nucleic Acids Res."},{"key":"48195_CR66","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"48195_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Research 9, 47 (2020).","journal-title":"F1000Research"},{"key":"48195_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1369\/00221554211007793","volume":"69","author":"M Willemsen","year":"2021","unstructured":"Willemsen, M., Krebbers, G., Bekkenk, M. W., Teunissen, M. B. M. & Luiten, R. M. Improvement of Opal multiplex immunofluorescence workflow for human tissue sections. J. Histochem. Cytochem. 69, 339\u2013346 (2021).","journal-title":"J. Histochem. Cytochem."},{"key":"48195_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2018.05.016","volume":"191","author":"S K\u00f6nig","year":"2019","unstructured":"K\u00f6nig, S. et al. Topographic protein profiling of the age-related proteome in the retinal pigment epithelium of Callithrix jacchus with respect to macular degeneration. J. Proteom. 191, 1\u201315 (2019).","journal-title":"J. Proteom."},{"key":"48195_CR70","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"48195_CR71","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48195-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48195-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48195-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:02:16Z","timestamp":1715792536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48195-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48195"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48195-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.M.z.H. received compensation for serving on scientific advisory boards (LFB, Roche, Immunovant) and speaker honoraria (Alexion, LFB, Argenx). H.W. is acting as a paid consultant for AbbVie, Actelion, Biogen, IGES, Johnson & Johnson, Novartis, Roche, Sanofi-Aventis and the Swiss Multiple Sclerosis Society. C.K. received lecture and consultancy fees from Biogen, Roche and Novartis. T.H. received lecture and consultancy fees from Biogen, Roche and Novartis, as well as research support from Biogen, Roche and Novartis Gene Therapies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4120"}}